All industry news
New productsJune 9, 2026

Stevanato unveils Deora pen injector for diabetes and weight management

Stevanato Group launched Deora, a multi-use, fixed-dose pen injector for subcutaneous delivery of diabetes and weight-management therapies. The device is positioned for use across multiple drug development programs.

The source

This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.

Read the full story at Medical Device Network
MedIndexer aggregates and summarises publicly available headlines. Full article text remains the property of the originating publication.